Amarin Corporation plc (ADR) (NASDAQ:AMRN) commented on new data from the CHERRY study that supports the hypothesis under investigation in Amarin’s cardiovascular outcomes study …
Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the encore presentation of findings from a post-hoc analysis examining the effects of icosapent ethyl (Vascepa®) on Apolipoprotein …
Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today the promotion …
Oppenheimer analyst Akiva Felt weighed in with a few insights on Amarin Corporation plc (ADR)(NASDAQ:AMRN), after the pharmaceutical company released its second-quarter results last week. …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced a United States District Court has ruled that Amarin may promote to healthcare professionals certain uses of Amarin’slead …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of findings from two studies, a retrospective study in which patients were switched from an EPA …
PhotoMedex Inc (NASDAQ:PHMD) shares soared 24.5% in pre-market trading to $2.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of findings from a new in vitro study at the National Lipid Association Scientific Sessions being held …
